Ambys Medicines Company Profile

04:42 EDT 22nd March 2019 | BioPortfolio

Ambys Medicines is a biotechnology company focused on discovering and developing transformative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today. Ambys was launched in 2018 by Third Rock Ventures and Takeda Pharmaceuticals, and is headquartered in Redwood City, Calif. For more information, please visit

News Articles [385 Associated News Articles listed on BioPortfolio]

NGM Bio’s Jeff Jonker Joins Ambys Medicines as President & CEO

Jeff Jonker has been appointed president and CEO of Ambys Medicines. Jonker comes to the Redwood City, CA-based biotech from NGM Bio, where he was president. His experience also includes senior positi...

Jeff Jonker Joins Ambys Medicines as President and CEO

-Company pursuing novel modalities including cell and gene therapies to regenerate the liver and restore liver function across multiple liver diseases- Ambys Medicines,...

Management tracks: Ambys, Foghorn

Migraine treatment Ajovy among CHMP’s six endorsed medicines 

Six medicines have taken a giant leap toward winning approval in Europe having won the backing of the European Medicines Agency’s (EMA) human medicines committee (CHMP).

Seven medicines leap closer to EU approval

The European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.

New antibiotic and migraine drug among 13 medicines recommended by EMA

The European Medicines Agency has recommended 13 medicines for approval, including three orphan medicines.

Eight medicines recommended in final London CHMP meeting

The first treatment for a rare disease characterised by high levels of triglycerides in blood is among eight new medicines put forward by the European Medicines Agency'a human medicines committee (CHM...

UK crackdown yields £2m of counterfeit medicines

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has seized more than one million doses of fake medicines with...Read More... The post UK crackdown yields £2m of counterfeit medicine...

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Good sense heartburn relief [bryant ranch prepack]

Perrigo Heartburn Relief Drug Facts

Clonazepam [st marys medical park pharmacy]

Clonazepam Tablets, USP CIV Rx only,

Testo-100 [advanced pharmaceutical technology, inc.]


Mometasone furoate [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use MOMETASONE FUROATE CREAM safely and effectively. See full prescribing information for MOMETASONE FUROATE CREAM. MOMETASONE FUROATE Cre...

PubMed Articles [218 Associated PubMed Articles listed on BioPortfolio]

Lost medicines: a longer view of the pharmaceutical industry with the potential to reinvigorate discovery.

It is widely understood that the 1962 Kefauver-Harris Amendment to the Food, Drug and Cosmetics Act ushered in the modern regulation of medicines requiring a combination of safety and efficacy. Howeve...

Review: The Health Consequences of Falsified Medicines.

To analyse and present the literature describing the health consequences of falsified medicines, focusing on mortality and morbidity, as well as the scale of the issue, the geographic extent, the medi...

Te Wero tonu-the challenge continues: Māori access to medicines 2006/07-2012/13 update.

Analysis of dispensings of prescription medicines in New Zealand in 2006/07 reported large inequities between Māori and non-Māori. This present study has now updated the earlier work by describing v...

Pharmacists and patients sharing decisions about medicines: Development and feasibility of a conversation guide.

In Australia, the Home Medicines Review (HMR) is a nationally-funded program, led by pharmacists to optimize medication use for older people. A Medicines Conversation Guide was developed for pharmacis...

Impact of Brexit on UK and EU Drug Regulation and Patient Access.

The chronology of U.K. leaving the European Union Is presented together with its implications for medicines regulation, including the move of the European Medicines Agency from London to Amsterdam, Th...

Clinical Trials [482 Associated Clinical Trials listed on BioPortfolio]

Tuberculosis Treatment Shortening Trial

Tuberculosis (TB) is a serious infection that can affect the lungs and other parts of the body. The usual way to treat TB is to take 4 medicines by mouth every day for 2 months, then take ...

Medicines Reconciliation at an Intensive Care Unit

This study evaluates the effect of performing medicines reconciliation on patients admitted to an intensive care unit. Half of the patients will receive a medicines reconciliation at the i...

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

The purpose of this study is to find out whether taking certain anti-HIV medicines with certain antimalarial medicines affects the amount of the medicines in the blood. The study medicine...

Carefully seLected and Easily Accessible at No Charge Medications Randomized Controlled Trial

This trial evaluates the effect of providing primary care patients with free and convenient access to a set of essential medicines. Half of the participants will receive free and convenien...

Development of the Medicines Optimisation Assessment Tool

The purpose of this study is to develop a prediction-tool, the Medicines Optimisation Assessment Tool (MOAT), to assist hospital pharmacists identify patients at highest risk of preventabl...

Companies [608 Associated Companies listed on BioPortfolio]

Ambys Medicines

Ambys Medicines is a biotechnology company focused on discovering and developing transformative therapies for people with advanced liver disease. Founded by world-renowned experts...

Ligand Pharmaceuticals Incorporated and The Medicines Company

The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise m...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...


Alphapharm is one of Australia's leading pharmaceutical companies. We develop, manufacture, market and distribute prescription medicines and medicines only available at pharmacies. Our speciality is b...

Rosemont Pharmaceuticals Ltd.

Rosemont are the leading specialists in oral liquid medicines for people who have swallowing difficulties (dysphagia). We are dedicated to the development, manufacturing and marketing of oral liquid m...

More Information about "Ambys Medicines" on BioPortfolio

We have published hundreds of Ambys Medicines news stories on BioPortfolio along with dozens of Ambys Medicines Clinical Trials and PubMed Articles about Ambys Medicines for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ambys Medicines Companies in our database. You can also find out about relevant Ambys Medicines Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Corporate Database Quicklinks

Searches Linking to this Company Record